4
Changes in Ownership
Compass Therapeutics, Inc. Filed Acc 0001213900-20-015638
Chief Executive Officer bought 97,431 shares at $5.00 ($487,155)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schuetz Thomas J. Chief Executive Officer | 2020-06-19 | Purchase | +97,431 | $5.00 | $487,155 | 4,525,467 | D |
| Open-market purchases · 97,431 sh · avg $5.00 · $487,155 | |||||||
Loading xslF345X03/ownership.xml…